<DOC>
	<DOCNO>NCT00742833</DOCNO>
	<brief_summary>To investigate efficacy safety KUC-7483 overactive bladder patient .</brief_summary>
	<brief_title>A Phase II Study KUC-7483 Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder , Overactive</mesh_term>
	<mesh_term>p-Hydroxyamphetamine</mesh_term>
	<criteria>Patients symptom overactive bladder 6 month . Patients meet following condition 3day bladder diary period . mean number micturition per 24 hour ≥8 time mean number urgency episodes per 24 hour ≥1 time Patients diagnose stress urinary incontinence predominant . Patients urinary calculus , interstitial cystitis , clinically significant urinary tract infection .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Overactive bladder</keyword>
	<keyword>Frequency</keyword>
	<keyword>Micturition</keyword>
	<keyword>Urgency</keyword>
	<keyword>Urge urinary incontinence</keyword>
	<keyword>β3-agonist</keyword>
</DOC>